OBJECTIVE： To explore the role of clinical pharmacists on immunochemotherapy for follicular lymphoma patients with hepatitis C. METHODS： Clinical pharmacists participated in the treatment process for a follicular lymphoma patient with hepatitis C. Clinical pharmacist suggested patient to initially take liver protection， white blood cell and platelet increasing therapy， and take rituximab immunochemotherapy after liver function and hemogram improved. During treatment， liver function and hepatitis C virus RNA （HCV-RNA） load should be monitored closely. After the completion of immunochemotherapy， the patient’s lymphoma was completely relieved and then anti-HCV treatment could be considered. RESULTS： Physicians adopted the suggestions of clinical pharmacists， and prescribed intravenous dripping of rituximab 600 mg to the patient. The immunochemotherapy was carried out smoothly， the patient didn’t feel discomfort and then discharged from hospital. CONCLUSIONS： The participation of clinical pharmacists in the formulation of individual medication plan， which promotes rational drug use and guarantee the safety of drug use.